GROKEN BIOSCIENCE

Applied Biomolecular Technologies (ABT) provides R&D services in molecular biology and protein biochemistry. We specialize in solving difficult problems, such as genes that express poorly or proteins that are unstable or need refolding. Our experienced scientists and laboratory staff are well equipped to assist in problem analysis, program design and laboratory execution.

ATDBio is a UK-based SME with laboratories in Southampton and Oxford, specialising in the synthesis of highly pure DNA oligonucleotides.

ATDBio makes oligonucleotides that are used in academic and commercial research in the fields of genetics, genomics, molecular biology, biochemistry, biotechnology and nanotechnology, including some of the world's largest biotech companies. We supply a wide range of custom-made unmodified and chemically modified oligonucleotides for small and large scale applications. Collectively, we have well over 50 years' experience in nucleic acids chemistry and oligo synthesis, and we are at the forefront of nucleic acids research.

ATDBio was founded in 2005 by Prof. Tom Brown, Professor of Nucleic Acids Chemistry at the University of Oxford and one of the world's leading nucleic acid chemists, and Dr Dorcas Brown, an expert in oligonucleotide synthesis.

ATDBio has recently heavily invested in increasing its R&D capabilities by expanding both the main site in Southampton and developing a new dedicated R&D site at the Oxford Science Park, including new equipment for the synthesis, analysis and purification of oligonucleotides.

Bio Basic Inc. is a biotechnology company founded in Toronto, Canada. Since its inception, Bio Basic has developed rapidly by manufacturing various Life Science Products and has served as a one-stop-stop for researchers in the Life Sciences.

Bio Basic strongly committed to innovation and excellence. It strives to do so by directing its efforts into R & D and improving the quality of its products. Bio Basic offers a wide variety of products and services, especially in the field of molecular biology. Several product lines from Bio Basic such as, Molecular Biology Kits, Biochemicals, Synthetic Genes, Peptides and Oligomers have already shown a dominant market presence and have been widely recognized by researchers worldwide.

Bio Basic distinguishes itself from our other competitors by:
1. Being a direct manufacturer of its own product lines, thereby guaranteeing the most competitive prices on the market.
2. Providing a wide range of products and services, to assist with many areas of Life Science Research.
3. Strict quality control – Bio Basic ensures that the quality of its products and services meet the highest in global standards through continuous process improvement and vigorous R&D.
4. Its mission to make high quality research products and services affordable to any lab.

Bio Basic's Product Lines:
Molecular Biology Kits
Culture Media
Biochemicals
Electrophoresis Reagents (including DNA, RNA and Protein Markers)
PCR Reagents
Pre-made Recombinant Protein
Labware
Benchtop Equipment

Bio Basic's Services:
Gene Synthesis
Oligo Synthesis
Protein Production
Peptide Synthesis
Antibody Production
DNA Sequencing

Our Mission:
“To provide the highest quality products and services at the most affordable rates in the industry”.

Our Vision:
“To make quality research affordable to any lab, anywhere, thereby allowing scientific breakthroughs to ourish”.

Our Values:
“To deliver an unparalleled quality of service as a team with great care, passion and integrity”.

Since its founding in 1992 Bioneer Corporation has established market leadership in Korea for most of the products it manufactures. Bioneer has built its business by providing researchers with superior, high quality products at excellent value. Over the years, Bioneer has developed a broad range of unique products that provide total genomic research solutions for life sciences research including genomics, nucleic acid-based molecular diagnostics and gene therapy studies.
Bioneer has extensive R&D experience in developing new drugs as well as the use of siRNA and drug delivery systems, and provides unrivalled service and support for such tools. For example, through the creation, development, and commercialization of the S. pombe deletion mutant library, Bioneer provides an innovative tool for improving the development of new drugs. The S. pombe library accurately predicts the toxicity of drug candidates for anti-cancer, Hyperlipidemia and also provides molecular level mechanism analysis of natural compound drugs. The company is headquartered in South Korea with an oligonucleotide manufacturing facility in the U.S., a regional office in China, and is supported by a network of distributors throughout the world. For more information, please visit www.bioneer.com.

Gen-X Diagnostics is a unit of ARA Healthcare Pvt. Ltd. was founded by leading applied research scientist Dr. Rama Mukherjee, specializes in the field of molecular diagnostics.

It is one of the first of its kind R&D Company focusing on development of genetic, biological and molecular diagnostic services with an intention to assisting its global partners in shortening the cycle and lowering the cost of drug discovery and development by providing cost effective and efficient co-development and outlicencing solution.

Gen X Diagnostics is a unique leading Molecular Diagnostics in India offering a wide range of tests for infectious diseases, transplantation medicine, prenatal diagnostics, cancer, genetic disorder, metabolic and hormonal disorders. Gen-X Diagnostics has started its diagnostics operation from Dec 2007.